- ARPA-H puts $160M into bespoke drug therapies; Biohaven switches up scientific leadership<figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…BioPharma Dive · 16d ago↗ source
- FDA quietly pushes back deadline on electric shock banMassachusetts' biggest nursing strike ever, tackling the male loneliness epidemic, and other health news for Morning RoundsSTAT · 16d ago↗ source
- The data that led Cellular Intelligence to pick up Novo's Parkinson's stem cell therapyMONTREAL — After Novo Nordisk closed its cell therapy unit, Cellular Intelligence contracted neurologist and drug developer Nuno Mendonça to conduct due diligence on the Danish pharma’s Parkinson’s…